BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (NASDAQ:CCRN) today announced financial results in line with its expectations for the fourth quarter and full year ended December 31, 2015.
FOURTH QUARTER FINANCIAL HIGHLIGHTS:
- Revenue was $193.1 million, up 3% both on a year-over-year and pro forma basis
- Adjusted EBITDA was $10.9 million or 5.7% of revenue versus $6.2 million or 3.3% of revenue in the prior year
- Adjusted earnings per share (EPS) was $0.18 compared to $0.03 in the prior year
FULL YEAR FINANCIAL HIGHLIGHTS:
- Revenue was $767.4 million, up 24% year-over-year and 5% on a pro forma basis
- Adjusted EBITDA was $37.6 million or 4.9% of revenue versus $17.2 million or 2.8% of revenue in the prior year
- Adjusted EPS was $0.54 compared to $0.09 in the prior year
- Cash flow from operations was $18.2 million compared to cash flow used in operations of $4.1 million
Note: Refer to table and discussion of Non-GAAP financial measures below.
“This was a year of significant improvement for Cross Country Healthcare. After only the second full year executing our turnaround plan, I am extremely pleased with the progress we are making. We continue to execute on our strategy as a leader in healthcare staffing and as a provider of value-added workforce solutions,” said William J. Grubbs, President and Chief Executive Officer. “We reached our fourth quarter Adjusted EBITDA target of 5% one quarter early and exceeded that goal for both the third and fourth quarters. Full year Adjusted EBITDA grew by more than $20 million to 4.9% representing a 210 basis point improvement. The market remains robust and we expect 2016 to be another year of providing our shareholders with superior returns.”
Fourth quarter consolidated revenue was $193.1 million, an increase of 3% year-over-year and a decrease of 1% sequentially. On a pro forma basis, fourth quarter revenue was up 3% year-over-year. The Company's consolidated gross profit margin was 26.1%, up 80 basis points year-over-year and down 20 basis points sequentially. Adjusted EBITDA was $10.9 million or 5.7% of revenue, as compared with $6.2 million or 3.3% of revenue in the prior year. Net loss attributable to common shareholders was $6.1 million, or $0.19 per diluted share, compared to a net loss of $20.2 million or $0.65 per diluted share in the prior year. Adjusted EPS was $0.18 compared to $0.03 in the prior year and $0.23 in the prior quarter.
For the year ended December 31, 2015, consolidated revenue was $767.4 million, an increase of 24% year-over-year. On a pro forma basis, revenue was up 5% year-over-year. Consolidated gross profit margin was 25.7%, up 20 basis points from the prior year. Adjusted EBITDA was $37.6 million or 4.9% of revenue, as compared with $17.2 million or 2.8% of revenue in the prior year. Net income attributable to common shareholders was $4.4 million, or $0.14 per diluted share, compared to a net loss of $31.8 million or $1.02 per diluted share in the prior year. Adjusted EPS was $0.54 compared to $0.09 in the prior year.
Quarterly Business Segment Highlights
Nurse and Allied Staffing
Revenue from Nurse and Allied Staffing increased 10% year-over-year and 3% sequentially. Contribution income in this segment was $15.1 million, up from $11.2 million in the prior year. The year-over-year increase in segment revenue and contribution income resulted from organic growth, improved margins, and the impact of the Mediscan acquisition. Average field FTEs increased to 6,792 from 6,340 in the prior year. Revenue per FTE per day was $259 compared to $253 in the prior year, driven primarily by improved pricing.
Physician Staffing
Revenue from Physician Staffing decreased 10% year-over-year and 12% sequentially, primarily due to a decrease in volume. Contribution income was $2.7 million, up from $2.5 million in the prior year resulting from improvement in gross margins and lower SG&A costs, partly offset by volume declines. Compared to the prior year, total days filled decreased to 18,131 from 19,873 and revenue per day filled decreased to $1,392 from $1,485 due to the mix of business.
Other Human Capital Management Services
Revenue from Other Human Capital Management Services was $3.8 million, a decrease of 64% year-over-year and 49% sequentially as a result of the divestiture of the education seminars business. Contribution income was $0.1 million, compared to $0.6 million in the prior year.
Cash Flow and Balance Sheet Highlights
Cash flow used in operating activities was $0.6 million compared to $1.0 million used in the same period of the prior year. Cash flow provided by operating activities for the full year was $18.2 million compared to $4.1 million used in the prior year. At December 31, 2015, the Company had $2.5 million in cash and cash equivalents, $8.0 million drawn on its senior credit facility, and $55.0 million of subordinated debt at par. The Company had $40.1 million of availability under the senior credit facility at December 31, 2015.
Outlook for First Quarter and Full Year 2016
| Q1 2016 Range | Year-over-Year | |||
| Change | ||||
| Revenue | $195 million - $198 million | 5% - 6% | ||
| Gross profit margin | 25.0% - 25.5% | (30) - 20 bps | ||
| Adjusted EBITDA margin | 3.7% - 4.2% | 40 - 90 bps | ||
| Adjusted EPS | $0.06 - $0.08 | $0.03 - $0.05 | ||
| FY 2016 Range | Year-over-Year | |||
| Change | ||||
| Revenue | $820 million - $840 million | 7% - 9% | ||
| Adjusted EBITDA margin | 5.5% - 6.0% | 60 - 110 bps |
In addition to providing quarterly guidance for the first quarter, the Company also is issuing full year 2016 estimates for Revenue and Adjusted EBITDA margin. The full year estimate for Adjusted EBIITDA margin reflects approximately $4 - $5 million in planned investments, primarily for upgrades to existing IT related platforms, with approximately $1 million expected to be incurred in the first quarter. The quarterly guidance reflects approximately 80 basis points for costs associated with the annual payroll tax reset and 50 basis points for the impact from incremental investments. Excluding the combined impact from those costs, would imply an underlying Adjusted EBITDA margin of between 5.0 - 5.5% for the quarter, in line with our recent quarterly trends. Excluding the impact of the IT investments for the full year, our underlying Adjusted EBITDA margin for the full year would be between 6.0-6.5%.
The estimates above are based on current management expectations and, as such, are forward-looking and actual results may differ materially. These ranges do not include the potential impact of any future divestitures, mergers, acquisitions or other business combinations, any impairment charges or valuation allowances, any acquisition-related measurement period adjustments, or any material legal or restructuring charges.
INVITATION TO CONFERENCE CALL
The Company will hold its quarterly conference call on Thursday, March 10, 2016, at 9:00 A.M. Eastern Time to discuss its fourth quarter and full year 2015 financial results. This call will be webcast live and can be accessed at the Company's website at www.crosscountryhealthcare.com or by dialing 800-857-6331 from anywhere in the U.S. or by dialing 517-623-4781 from non-U.S. locations - Passcode: Cross Country. A replay of the webcast will be available from March 10th through March 24th at the Company's website and a replay of the conference call will be available by telephone by calling 800-395-7443 from anywhere in the U.S. or 203-369-3271 from non-U.S. locations - Passcode: 2016.
ABOUT CROSS COUNTRY HEALTHCARE
Headquartered in Boca Raton, Florida, Cross Country Healthcare, Inc. is a national leader in providing leading-edge healthcare workforce solutions. Our solutions are geared towards assisting our clients solve labor-related issues while maintaining high quality outcomes. With more than 30 years of experience, we are dedicated to placing highly qualified nurses and physicians as well as allied health, advanced practice, and case management professionals. We also provide both retained and contingent placement services for physicians, as well as retained search services for healthcare executives. We have more than 9,500 active contracts with a broad range of clients in both clinical and nonclinical settings, including acute care hospitals, physician practice groups, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and homecare. Through our national staffing teams and network of more than 70 branch office locations, we are able to place clinicians on travel and per diem assignments, local short-term contracts and permanent positions. We are a market leader in providing flexible workforce management solutions, which include managed services programs (MSP), internal resource pool consulting and development, electronic medical record (EMR) transition staffing, recruitment process outsourcing, predictive modeling and consultative services.
Copies of this and other news releases as well as additional information about Cross Country Healthcare can be obtained online at www.crosscountryhealthcare.com. Shareholders and prospective investors can also register to automatically receive the Company's press releases, SEC filings and other notices by e-mail.
NON-GAAP FINANCIAL MEASURES
This press release and accompanying financial statement tables reference non-GAAP financial measures. Such non-GAAP financial measures are provided as additional information and should not be considered substitutes for, or superior to, financial measures calculated in accordance with U.S. GAAP. Such non-GAAP financial measures are provided for consistency and comparability to prior year results; furthermore, management believes they are useful to investors when evaluating the Company's performance as they exclude certain items that management believes are not indicative of the Company's operating performance. Pro forma measures are adjusted to include the results of our acquisitions, and exclude the results of divestments, as if the transactions occurred in the beginning of the periods mentioned. Such non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. The financial statement tables that accompany this press release include a reconciliation of each non-GAAP financial measure to the most directly comparable U.S. GAAP financial measure and a more detailed discussion of each financial measure; as such, the financial statement tables should be read in conjunction with the presentation of these non-GAAP financial measures.
FORWARD-LOOKING STATEMENT
In addition to historical information, this press release contains statements relating to our future results (including certain projections and business trends) that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are subject to the “safe harbor” created by those sections. Forward-looking statements consist of statements that are predictive in nature, depend upon or refer to future events. Words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “estimates”, “suggests”, “appears”, “seeks”, “will”, and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. These factors include, but are not limited to, the following: our ability to attract and retain qualified nurses, physicians and other healthcare personnel, costs and availability of short-term housing for our travel healthcare professionals, demand for the healthcare services we provide, both nationally and in the regions in which we operate, the functioning of our information systems, the effect of cyber security risks and cyber incidents on our business, the effect of existing or future government regulation and federal and state legislative and enforcement initiatives on our business, our clients' ability to pay us for our services, our ability to successfully implement our acquisition and development strategies, including our ability to successfully integrate acquired businesses and realize synergies from such acquisitions, the effect of liabilities and other claims asserted against us, the effect of competition in the markets we serve, our ability to successfully defend the Company, its subsidiaries, and its officers and directors on the merits of any lawsuit or determine its potential liability, if any, and other factors set forth in Item 1A. “Risk Factors” in the Company's Annual Report on Form 10-K for the year ended December 31, 2014, and our other Securities and Exchange Commission filings made prior to the date hereof.
Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results and readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's opinions only as of the date of this press release. There can be no assurance that (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors' likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct or (iv) our strategy, which is based in part on this analysis, will be successful. The Company undertakes no obligation to update or revise forward-looking statements. All references to “we”, “us”, “our”, or “Cross Country” in this press release mean Cross Country Healthcare, Inc. and its subsidiaries.
| Cross Country Healthcare, Inc. | |||||||||||||||||||||||
| Consolidated Statements of Operations | |||||||||||||||||||||||
| (Unaudited, amounts in thousands, except per share data) | |||||||||||||||||||||||
| Three Months Ended | Year Ended | ||||||||||||||||||||||
| December 31, | December 31, | September 30, | December 31, | December 31, | |||||||||||||||||||
| 2015 | 2014 | 2015 | 2015 | 2014 | |||||||||||||||||||
| Revenue from services | $ | 193,148 | $ | 188,134 | $ | 195,692 | $ | 767,421 | $ | 617,825 | |||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Direct operating expenses | 142,669 | 140,493 | 144,206 | 570,056 | 460,021 | ||||||||||||||||||
| Selling, general and administrative expenses | 39,991 | 41,538 | 39,227 | 161,275 | 141,018 | ||||||||||||||||||
| Bad debt expense | 228 | 295 | 549 | 999 | 1,016 | ||||||||||||||||||
| Depreciation | 954 | 1,070 | 953 | 3,856 | 3,866 | ||||||||||||||||||
| Amortization | 1,263 | 995 | 982 | 4,210 | 3,575 | ||||||||||||||||||
| Loss on sale of business (a) | — | — | 2,184 | 2,184 | — | ||||||||||||||||||
| Acquisition and integration costs (b) | 160 | 2,532 | 584 | 902 | 7,957 | ||||||||||||||||||
| Restructuring costs | 127 | 85 | 140 | 1,274 | 840 | ||||||||||||||||||
| Impairment charges (c) | 2,100 | 10,000 | — | 2,100 | 10,000 | ||||||||||||||||||
| Total operating expenses | 187,492 | 197,008 | 188,825 | 746,856 | 628,293 | ||||||||||||||||||
| Income (loss) from operations | 5,656 | (8,874 | ) | 6,867 | 20,565 | (10,468 | ) | ||||||||||||||||
| Other expenses (income): | |||||||||||||||||||||||
| Interest expense | 1,647 | 1,784 | 1,654 | 6,810 | 4,160 | ||||||||||||||||||
| Loss on derivative liability | 9,516 | 9,363 | 2,894 | 9,901 | 16,671 | ||||||||||||||||||
| Other (income) expense, net | (276 | ) | (46 | ) | (100 | ) | (306 | ) | 19 | ||||||||||||||
| (Loss) income before income taxes | (5,231 | ) | (19,975 | ) | 2,419 | 4,160 | (31,318 | ) | |||||||||||||||
| Income tax expense (benefit) | 696 | 112 | (2,732 | ) | (794 | ) | 216 | ||||||||||||||||
| Consolidated net (loss) income | (5,927 | ) | (20,087 | ) | 5,151 | 4,954 | (31,534 | ) | |||||||||||||||
| Less: Net income attributable to noncontrolling interest in subsidiary | 171 | 131 | 142 | 536 | 249 | ||||||||||||||||||
| Net (loss) income attributable to common shareholders | $ | (6,098 | ) | $ | (20,218 | ) | $ | 5,009 | $ | 4,418 | $ | (31,783 | ) | ||||||||||
| Net (loss) income per share attributable to common shareholders - Basic and Diluted | $ | (0.19 | ) | $ | (0.65 | ) | $ | 0.16 | $ | 0.14 | $ | (1.02 | ) | ||||||||||
| Weighted average common shares outstanding: | |||||||||||||||||||||||
| Basic | 31,817 | 31,264 | 31,541 | 31,514 | 31,190 | ||||||||||||||||||
| Diluted (d) | 31,817 | 31,264 | 32,168 | 32,162 | 31,190 | ||||||||||||||||||
| Cross Country Healthcare, Inc. | |||||||||||||||||||||||
| Reconciliation of Non-GAAP Financial Measures | |||||||||||||||||||||||
| (Unaudited, amounts in thousands) | |||||||||||||||||||||||
| Three Months Ended | Year Ended | ||||||||||||||||||||||
| December 31, | December 31, | September 30, | December 31, | December 31, | |||||||||||||||||||
| 2015 | 2014 | 2015 | 2015 | 2014 | |||||||||||||||||||
| Adjusted EBITDA: (e) | |||||||||||||||||||||||
| Consolidated net (loss) income attributable to common shareholders | $ | (6,098 | ) | $ | (20,218 | ) | $ | 5,009 | $ | 4,418 | $ | (31,783 | ) | ||||||||||
| Depreciation | 954 | 1,070 | 953 | 3,856 | 3,866 | ||||||||||||||||||
| Amortization | 1,263 | 995 | 982 | 4,210 | 3,575 | ||||||||||||||||||
| Interest expense | 1,647 | 1,784 | 1,654 | 6,810 | 4,160 | ||||||||||||||||||
| Income tax expense (benefit) | 696 | 112 | (2,732 | ) | (794 | ) | 216 | ||||||||||||||||
| Acquisition and integration costs (b) | 160 | 2,532 | 584 | 902 | 7,957 | ||||||||||||||||||
| Restructuring costs | 127 | 85 | 140 | 1,274 | 840 | ||||||||||||||||||
| Loss on derivative liability | 9,516 | 9,363 | 2,894 | 9,901 | 16,671 | ||||||||||||||||||
| Loss on sale of business (a) | — | — | 2,184 | 2,184 | — | ||||||||||||||||||
| Other (income) expense, net | (276 | ) | (46 | ) | (100 | ) | (306 | ) | 19 | ||||||||||||||
| Impairment charges (c) | 2,100 | 10,000 | — | 2,100 | 10,000 | ||||||||||||||||||
| Equity compensation | 687 | 429 | 557 | 2,460 | 1,387 | ||||||||||||||||||
| Net income attributable to noncontrolling interest in subsidiary | 171 | 131 | 142 | 536 | 249 | ||||||||||||||||||
| Adjusted EBITDA (e) | $ | 10,947 | $ | 6,237 | $ | 12,267 | $ | 37,551 | $ | 17,157 | |||||||||||||
| Adjusted EPS: (f) | |||||||||||||||||||||||
| Reported diluted EPS | $ | (0.19 | ) | $ | (0.65 | ) | $ | 0.16 | $ | 0.14 | $ | (1.02 | ) | ||||||||||
| Acquisition and integration costs (b) | — | 0.05 | 0.01 | 0.02 | 0.15 | ||||||||||||||||||
| Restructuring costs | — | — | — | 0.02 | 0.02 | ||||||||||||||||||
| Impairment charges (c) | 0.04 | 0.29 | — | 0.04 | 0.29 | ||||||||||||||||||
| Gain on sale of business, after taxes (a) | — | — | (0.04 | ) | (0.04 | ) | — | ||||||||||||||||
| Loss on derivative liability | 0.18 | 0.18 | 0.06 | 0.19 | 0.32 | ||||||||||||||||||
| Valuation allowance on adjusted items | 0.15 | 0.15 | 0.04 | 0.17 | 0.32 | ||||||||||||||||||
| Adjustment for change in dilutive shares (f) | — | 0.01 | — | — | 0.01 | ||||||||||||||||||
| Adjusted EPS (f) | $ | 0.18 | $ | 0.03 | $ | 0.23 | $ | 0.54 | $ | 0.09 | |||||||||||||
| Weighted average common shares outstanding - diluted | 31,817 | 31,264 | 32,168 | 32,162 | 31,190 | ||||||||||||||||||
| Adjustment to diluted shares (f) | 684 | 447 | — | — | 335 | ||||||||||||||||||
| Adjusted weighted average common shares - diluted | 32,501 | 31,711 | 32,168 | 32,162 | 31,525 | ||||||||||||||||||
| Cross Country Healthcare, Inc. | |||||||||||||||||||||||
| Consolidated Balance Sheets | |||||||||||||||||||||||
| (Unaudited, amounts in thousands) | |||||||||||||||||||||||
| December 31, | December 31, | ||||||||||||||||||||||
| 2015 | 2014 | ||||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Current assets: | |||||||||||||||||||||||
| Cash and cash equivalents | $ | 2,453 | $ | 4,995 | |||||||||||||||||||
| Accounts receivable, net | 146,873 | 113,129 | |||||||||||||||||||||
| Income taxes receivable | — | 307 | |||||||||||||||||||||
| Prepaid expenses | 4,521 | 6,073 | |||||||||||||||||||||
| Insurance recovery receivable | 2,866 | 5,624 | |||||||||||||||||||||
| Other current assets | 2,032 | 1,055 | |||||||||||||||||||||
| Total current assets | 158,745 | 131,183 | |||||||||||||||||||||
| Property and equipment, net | 10,470 | 12,133 | |||||||||||||||||||||
| Trade names, net | 39,252 | 38,201 | |||||||||||||||||||||
| Goodwill, net | 95,096 | 90,647 | |||||||||||||||||||||
| Other identifiable intangible assets, net | 43,662 | 33,823 | |||||||||||||||||||||
| Debt issuance costs, net | 878 | 1,257 | |||||||||||||||||||||
| Other non-current assets | 17,994 | 17,889 | |||||||||||||||||||||
| Total assets | $ | 366,097 | $ | 325,133 | |||||||||||||||||||
| Liabilities and Stockholders' Equity | |||||||||||||||||||||||
| Current liabilities: | |||||||||||||||||||||||
| Accounts payable and accrued expenses | $ | 41,098 | $ | 27,314 | |||||||||||||||||||
| Accrued employee compensation and benefits | 29,402 | 28,731 | |||||||||||||||||||||
| Current portion of long-term debt and capital lease obligations | 8,071 | 3,607 | |||||||||||||||||||||
| Sales tax payable | 2,411 | 2,573 | |||||||||||||||||||||
| Deferred purchase price | 2,184 | — | |||||||||||||||||||||
| Deferred tax liabilities | — | 1,981 | |||||||||||||||||||||
| Income tax payable | — | — | |||||||||||||||||||||
| Other current liabilities | 2,880 | 2,790 | |||||||||||||||||||||
| Total current liabilities | 86,046 | 66,996 | |||||||||||||||||||||
| Long-term debt and capital lease obligations | 81,803 | 70,467 | |||||||||||||||||||||
| Non-current deferred tax liabilities | 18,475 | 18,038 | |||||||||||||||||||||
| Long-term accrued claims | 30,070 | 32,068 | |||||||||||||||||||||
| Long-term deferred purchase price | 3,533 | 2,333 | |||||||||||||||||||||
| Other long-term liabilities | 4,826 | 4,899 | |||||||||||||||||||||
| Total liabilities | 224,753 | 194,801 | |||||||||||||||||||||
| Commitments and contingencies | |||||||||||||||||||||||
| Stockholders' equity: | |||||||||||||||||||||||
| Common stock | 3 | 3 | |||||||||||||||||||||
| Additional paid-in capital | 254,108 | 247,467 | |||||||||||||||||||||
| Accumulated other comprehensive loss | (1,207 | ) | (1,118 | ) | |||||||||||||||||||
| Accumulated deficit | (112,056 | ) | (116,474 | ) | |||||||||||||||||||
| Total Cross Country Healthcare, Inc. stockholders' equity | 140,848 | 129,878 | |||||||||||||||||||||
| Noncontrolling interest | 496 | 454 | |||||||||||||||||||||
| Total stockholders' equity | 141,344 | 130,332 | |||||||||||||||||||||
| Total liabilities and stockholders' equity | $ | 366,097 | $ | 325,133 | |||||||||||||||||||
|
|
|||||||||||||||||||||||||
| Cross Country Healthcare, Inc. | |||||||||||||||||||||||||
| Segment Data (g) | |||||||||||||||||||||||||
| (Unaudited, amounts in thousands) | |||||||||||||||||||||||||
| Three Months Ended |
Year-over- Year |
Sequential | |||||||||||||||||||||||
| December 31, | % of | December 31, | % of | September 30, | % of | % change | % change | ||||||||||||||||||
| 2015 | Total | 2014 | Total | 2015 | Total | Fav (Unfav) | Fav (Unfav) | ||||||||||||||||||
| Revenue from services: | |||||||||||||||||||||||||
| Nurse and Allied Staffing (h) | $ | 162,131 | 84% | $ | 147,381 | 78% | $ | 157,338 | 80% | 10.0% | 3.0% | ||||||||||||||
| Physician Staffing (h) | 27,236 | 14% | 30,361 | 16% | 30,959 | 16% | (10.3 )% | (12.0)% | |||||||||||||||||
| Other Human Capital Management Services | 3,781 | 2% | 10,392 | 6% | 7,395 | 4% | (63.6 )% | (48.9)% | |||||||||||||||||
| $ | 193,148 | 100% | $ | 188,134 | 100% | $ | 195,692 | 100% | 2.7 % | (1.3)% | |||||||||||||||
| Contribution income: (i) | |||||||||||||||||||||||||
| Nurse and Allied Staffing (h) | $ | 15,131 | $ | 11,207 | $ | 16,251 | 35.0 % | (6.9)% | |||||||||||||||||
| Physician Staffing (h) | 2,672 | 2,520 | 3,197 | 6.0% | (16.4)% | ||||||||||||||||||||
| Other Human Capital Management Services | 142 | 635 | 372 | (77.6)% | (61.8)% | ||||||||||||||||||||
| 17,945 | 14,362 | 19,820 | 24.9% | (9.5)% | |||||||||||||||||||||
| Unallocated corporate overhead | 7,685 | 8,554 | 8,110 | 10.2% | 5.2% | ||||||||||||||||||||
| Depreciation | 954 | 1,070 | 953 | 10.8% | (0.1)% | ||||||||||||||||||||
| Amortization | 1,263 | 995 | 982 | (26.9)% | (28.6)% | ||||||||||||||||||||
| Loss on sale of business (a) | — | — | 2,184 | NM | 100.0% | ||||||||||||||||||||
| Acquisition and integration costs (b) | 160 | 2,532 | 584 | 93.7% | 72.6% | ||||||||||||||||||||
| Restructuring costs | 127 | 85 | 140 | (49.4)% | 9.3% | ||||||||||||||||||||
| Impairment charges (c) | 2,100 | 10,000 | — | 79.0% | NM | ||||||||||||||||||||
| Income (loss) from operations | $ | 5,656 | $ | (8,874 | ) | $ | 6,867 | 163.7% | (17.6)% | ||||||||||||||||
| Year Ended |
Year-over- Year |
||||||||||||||||||||||||
| December 31, | % of | December 31, | % of | % change | |||||||||||||||||||||
| 2015 | Total | 2014 | Total | Fav (Unfav) | |||||||||||||||||||||
| Revenue from services: | |||||||||||||||||||||||||
| Nurse and Allied Staffing (h) | $ | 621,258 | 81% | $ | 459,195 | 74% | 35.3% | ||||||||||||||||||
| Physician Staffing (h) | 115,336 | 15% | 121,145 | 20% | (4.8)% | ||||||||||||||||||||
| Other Human Capital Management Services | 30,827 | 4% | 37,485 | 6% | (17.8)% | ||||||||||||||||||||
| $ | 767,421 | 100% | $ | 617,825 | 100% | 24.2% | |||||||||||||||||||
| Contribution income: (i) | |||||||||||||||||||||||||
| Nurse and Allied Staffing (h) | $ | 54,499 | $ | 36,486 | 49.4% | ||||||||||||||||||||
| Physician Staffing (h) | 10,213 | 6,540 | 56.2% | ||||||||||||||||||||||
| Other Human Capital Management Services | 1,863 | 514 | 262.5% | ||||||||||||||||||||||
| 66,575 | 43,540 | 52.9% | |||||||||||||||||||||||
| Unallocated corporate overhead | 31,484 | 27,770 | (13.4)% | ||||||||||||||||||||||
| Depreciation | 3,856 | 3,866 | 0.3% | ||||||||||||||||||||||
| Amortization | 4,210 | 3,575 | (17.8)% | ||||||||||||||||||||||
| Loss on sale of business (a) | 2,184 | — | NM | ||||||||||||||||||||||
| Acquisition and integration costs (b) | 902 | 7,957 | 88.7% | ||||||||||||||||||||||
| Restructuring costs | 1,274 | 840 | (51.7)% | ||||||||||||||||||||||
| Impairment charges (c) | 2,100 | 10,000 | 79.0% | ||||||||||||||||||||||
| Income (loss) from operations | $ | 20,565 | $ | (10,468 | ) | 296.5% | |||||||||||||||||||
| NM-Not meaningful. | |||||||||||||||||||||||||
| Cross Country Healthcare, Inc. | |||||||||||||||||||||||||
| Other Financial Data | |||||||||||||||||||||||||
| (Unaudited) | |||||||||||||||||||||||||
| Three Months Ended | Year Ended | ||||||||||||||||||||||||
| December 31, | December 31, | September 30, | December 31, | December 31, | |||||||||||||||||||||
| 2015 | 2014 | 2015 | 2015 | 2014 | |||||||||||||||||||||
| Net cash (used in) provided by operating activities (in thousands) | $ | (631 | ) | $ | (1,016 | ) | $ | 12,869 | $ | 18,235 | $ | (4,072 | ) | ||||||||||||
|
Nurse and Allied Staffing statistical data: |
|||||||||||||||||||||||||
| FTEs (h) (j) | 6,792 | 6,340 | 6,646 | 6,624 | 4,764 | ||||||||||||||||||||
| Average Nurse and Allied Staffing revenue per FTE per day (h) (k) | $ | 259 | $ | 253 | $ | 257 | $ | 257 | $ | 264 | |||||||||||||||
|
Physician Staffing statistical data: |
|||||||||||||||||||||||||
| Days filled (h) (l) | 18,131 | 19,873 | 20,543 | 77,601 | 82,473 | ||||||||||||||||||||
| Revenue per day filled (h) (m) | $ | 1,392 | $ | 1,485 | $ | 1,505 | $ | 1,463 | $ | 1,457 | |||||||||||||||
(a) On August 31, 2015, the Company completed the sale of Cross Country Education, LLC. The Company recognized a pre-tax loss of $2.2 million related to the divestiture of the business. In addition, the Company recorded a tax benefit of $3.5 million from the reversal of valuation allowances associated with this business, resulting in an after-tax gain of $1.3 million.
(b) Acquisition and integration costs in the three months and year ended December 31, 2015 and the three months ended September 30, 2015 are primarily related to due diligence efforts for the Mediscan acquisition that closed on October 30, 2015. In the three months ended December 31, 2014, acquisition and integration costs were from the June 2014 Medical Staffing Network Healthcare (MSN) acquisition, and in the year ended December 31, 2014, acquisition and integration costs were from both the MSN acquisition and the December 2013 allied healthcare staffing business acquisition. The results of these acquisitions have been included in the Company's consolidated statements of operations since their respective dates of acquisition.
(c) The fourth quarter of 2015 and 2014 include non-cash impairment charges of $2.1 million ($1.3 million after tax) and $10.0 million ($9.1 million after tax), respectively, related to Physician Staffing trade name. The tax impact on these impairment charges was fully offset by a valuation allowance on deferred tax assets.
(d) When applying the if-converted method to our Convertible Notes, 3,521,126 shares related to the Convertible Notes, issued in June 2014 in conjunction with the MSN acquisition, are not included in diluted weighted average shares for all of the periods presented because their effect was anti-dilutive.
(e) Adjusted EBITDA, a non-GAAP (Generally Accepted Accounting Principles) financial measure, is defined as net income (loss) attributable to common shareholders before depreciation, amortization, interest expense, income tax expense (benefit), acquisition and integration costs, restructuring costs, loss on derivative liability, loss on sale of business, other expense (income), net, impairment charges, equity compensation and net income attributable to noncontrolling interest in subsidiary. Adjusted EBITDA should not be considered a measure of financial performance under GAAP. Management presents Adjusted EBITDA because it believes that Adjusted EBITDA is a useful supplement to net income (loss) attributable to common shareholders as an indicator of operating performance. Management uses Adjusted EBITDA as one performance measure in its annual cash incentive program for certain members of its management team. In addition, management monitors Adjusted EBITDA for planning purposes. Adjusted EBITDA, as defined, closely matches the operating measure typically used in the Company's credit facilities in calculating various ratios. Management believes Adjusted EBITDA, as defined, is useful to investors when evaluating the Company's performance as it excludes certain items that management believes are not indicative of the Company's operating performance. Adjusted EBITDA Margin is calculated by dividing Adjusted EBITDA by the Company's consolidated revenue.
(f) Adjusted EPS, a non-GAAP financial measure, is defined as net income (loss) attributable to common shareholders per diluted share (reported EPS) before the diluted EPS impact of acquisition and integration costs, restructuring costs, impairment charges, loss on sale of business and loss on derivative liability. Adjusted EPS should not be considered a measure of financial performance under GAAP. Management presents Adjusted EPS because it believes that Adjusted EPS is a useful supplement to its reported EPS as an indicator of operating performance. Management believes it provides a more useful comparison of the Company's underlying business performance from period to period and is more representative of the future earnings capacity of the Company. For the three months ended December 31, 2015 and December 31, 2014 and the year ended December 31, 2014, the adjustments to reported diluted EPS had the effect of converting the net loss to net income. As a result, potentially dilutive shares that were excluded in the unadjusted per share calculation have been included in the adjusted weighted average common shares outstanding - diluted.
(g) Segment data provided is in accordance with the Segment Reporting Topic of the FASB ASC.
(h) Effective January 1, 2015, we reclassified a portion of our business from the Physician Staffing segment to the Nurse and Allied Staffing segment. Prior period amounts have been reclassified to conform to the current period presentation. The entire Mediscan business has been reported in Nurse and Allied Staffing.
(i) Contribution income is defined as income (loss) from operations before depreciation, amortization, loss on sale of business, acquisition and integration costs, restructuring costs, impairment charges and corporate expenses not specifically identified to a reporting segment. Contribution income is a financial measure used by management when assessing segment performance.
(j) FTEs represent the average number of Nurse and Allied Staffing contract personnel on a full-time equivalent basis.
(k) Average revenue per FTE per day is calculated by dividing the Nurse and Allied Staffing revenue by the number of days worked in the respective periods. Nurse and Allied Staffing revenue also includes revenue from permanent placement of nurses.
(l) Days filled is calculated by dividing the total hours filled during the period by 8 hours.
(m) Revenue per day filled is calculated by dividing the actual revenue invoiced by Physician Staffing by days filled for the period presented and it excludes permanent placement and accrued revenue.
